Faculty Information - YAMASHITA Kaoru

■ Published papers

1.	Original article	Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study. 2024/06
2.	Original article	Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. 2023/11
3.	Original article	Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus. 2023/10
4.	Original article	Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study - An Inseparable Relation with Hypertension and Chronic Kidney Disease 2023
5.	Original article	Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension. 2021/12
6.	Original article	Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study 2021/03/06
7.	Original article	Comparison of Shortened with Standard Saline Infusion Test for Primary Aldosteronism Diagnostics 2020/05/08
8.	Original article	Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism 2020/04/30
9.	Original article	Adrenal cortex hypoxia modulates aldosterone production in heart failure. 2020/03
10.	Original article	Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. 2019/12
11.	Case report	ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. 2019/05
12.	Original article	Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease. 2018
Display 5 items
Display all(12)

■ Academic conference presentation

1.	Primary adrenal insufficiency due to recurrent episodes of unilateral adrenal infarction （Poster notice，General） 2025/05
2.	Weekly Somapacitan Reduces Serum C-reactive Protein Levels in Adult Patients with Growth Hormone Deficiency （Poster notice，General） 2024/06/03
3.	Increased prevalence of uterine myoma in patients with idiopathic hyperaldosteronism （Poster notice，General） 2024/06/01
4.	A Case of Acromegaly Due to GH-secreting Tumor Mimicking ACTH Co-secretion （Poster notice，General） 2024/05
5.	Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism （Poster notice，General） 2024/05
6.	Romosozumab Therapy After Parathyroidectomy for Osteoporosis Caused by Primary Hyperparathyroidism: Two Case Reports （Poster notice，General） 2024/05
7.	A decrease in serum CRP levels after somapacitan therapy for adult growth hormone deficiency （Speech，General） 2024/02/16
8.	Growth hormone secretion and serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors （Poster notice，General） 2023/06/17
9.	A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass （Poster notice，General） 2023/05/15
10.	Renoprotective Effect of Aliskiren Monotherapy in Hypertensive Patients with Obesity and Type 2 Diabetes Mellitus （Poster notice，General） 2022/10/15
11.	Successful treatment with esaxerenone in a pregnant woman with primary aldosteronism and superimposed preeclampsia （Poster notice，General） 2022/10/14
12.	Usefulness of shortened saline infusion test for primary aldosteronism diagnostics （Poster notice，General） 2021/04/11
13.	Isolated pituitary sarcoidosis stained with a specific monoclonal antibody against Propionibacterium Acnes: A case report （Speech，General） 2020/02/21
14.	Two teenager cases whose liver transaminase elevated after growth hormone replacement （Speech，General） 2020/02/20
15.	A novel mechanism for aldosterone production through beta 3 adrenergic receptor (b3-AR) in heart failure （Poster notice，General） 2019/05/11
16.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism. （Poster notice，General） 2018/09/22
17.	Renoprotective Effect of Direct Renin Inhibitor Monotherapy in Hypertensive Patients with Type 2 Diabetes or Obesity （Speech，General） 2018/09/14
18.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism （Poster notice，General） 2018/09
19.	Primary aldosteronism patients have a correlation between organ dysfunctions and serum soluble (pro)renin receptor concentration. （Poster notice，General） 2018/04/29
20.	A novel mechanism for aldosterone production through beta 3 adrenergic receptor in hypoxia （Speech，General） 2017/12/09
21.	A novel mechanism for aldosterone production through beta 3 adrenergic receptor (β3-AR) in heart failure （Speech，General） 2016/09/27
22.	A novel biomarker urinary soluble (pro)renin receptor excretion is associated with urineph 2016/09
23.	Relationships between serum soluble (pro)renin receptor levels and endocrine or metabolic factors in patients with essential hypertension. 2015/09
24.	Isolated Pituitary Sarcoidosis Stained with a Specific Monoclonal Antibody against Propionibacterium Acnes: A Case Report （Poster notice，General） 2015/05/16
25.	A case of hemodialysis patient with primary aldosteronism which was difficult to differentiate from pheochromocytoma 2015/05
Display 5 items
Display all(25)

■ Conference activities & talks

1.

2019/07/27

A novel mechanism for aldosterone production through beta 3 adrenergic receptor (b3-AR) in hypertension-induced heart failure

■ Awards & honors

1.

2019/05

International Symposium of Aldosterone and Related Substances in Hypertension Gordon Williams Award

■ Academic society memberships

1.

2019/03～

Endocrine Society

■ Education

1.	2015/04～2019/03	〔Doctoral course〕〔Doctorial Course〕 Endocrinology, Graduate School, Division of Medical Sciences, Tokyo Women's Medical University, Completed,
2.	2006/04～2012/03	Faculty of Medicine, Tokyo Women's Medical University, Graduated

■ Rsearch funding number

50815420